Ellis Tania, Imrie Allison, Katz Alan R, Effler Paul V
Department of Public Health Sciences, John A. Burns School of Medicine, University of Hawaii at Manoa, Manoa, Hawaii, USA.
Vector Borne Zoonotic Dis. 2008 Aug;8(4):541-7. doi: 10.1089/vbz.2007.0241.
During the 10-year period from 1997 through 2006, the reported mean annual incidence rate of leptospirosis in the state of Hawaii was 3.3/100,000 with a range of 22-60 infections reported each year. Because the clinical presentation is highly variable, however, leptospirosis illness is challenging to recognize and may be underdiagnosed. To assess whether the incidence may be substantially higher than reported figures indicate, we retrospectively studied the prevalence of anti-Leptospira IgM antibodies among specimens obtained over a 12-month period (May 2001 to April 2002) from patients presenting with febrile illness during a dengue fever outbreak in Hawaii. Of 1206 patients testing negative or indeterminate for dengue, 54 (4.5%; 95% confidence interval: 3.3%-5.7%) were positive for anti-Leptospira IgM antibodies using a commercially available dipstick enzyme-linked immunosorbent assay (ELISA). The most common clinical symptoms reported by laboratory-positive leptospirosis patients were fever (92%), headache (88%), and myalgia (83%). Three clinical symptoms were significantly less common among persons laboratory positive for leptospirosis when compared with the 122 patients who had been diagnosed with dengue fever during the outbreak: rash (p < 0.0001), chills (p = 0.05), and petechiae (p = 0.0005). Laboratory-positive leptospirosis infections were identified in persons exposed on each of the 5 most populous islands and illness onsets spanned a 10-month period, reflecting an endemic pattern of disease. If added to the figures obtained via routine passive surveillance, the number of leptospirosis infections identified through this study would more than double the annual incidence rate for Hawaii during 2001. These findings indicate that many leptospiral infections in Hawaii go undiagnosed. Physicians should maintain a high index of suspicion for leptospirosis when assessing patients presenting with acute febrile illness among residents and visitors to Hawaii.
在1997年至2006年的10年期间,夏威夷州报告的钩端螺旋体病年平均发病率为3.3/10万,每年报告的感染病例数在22至60例之间。然而,由于临床表现高度多变,钩端螺旋体病很难识别,可能存在诊断不足的情况。为了评估发病率是否可能远高于报告数字所示,我们回顾性研究了在夏威夷登革热疫情期间,于2001年5月至2002年4月这12个月内从发热疾病患者身上采集的标本中抗钩端螺旋体IgM抗体的流行情况。在1206例登革热检测呈阴性或结果不确定的患者中,使用市售的试纸条酶联免疫吸附测定(ELISA)法检测,有54例(4.5%;95%置信区间:3.3%-5.7%)抗钩端螺旋体IgM抗体呈阳性。实验室确诊的钩端螺旋体病患者报告的最常见临床症状为发热(92%)、头痛(88%)和肌痛(83%)。与疫情期间确诊为登革热的122例患者相比,实验室确诊的钩端螺旋体病患者出现的三种临床症状明显较少见:皮疹(p<0.0001)、寒战(p = 0.05)和瘀点(p = 0.0005)。在人口最多的5个岛屿上,每个岛屿都有实验室确诊的钩端螺旋体病感染病例,发病时间跨度为10个月,反映出该病的地方流行模式。如果将本研究确定的钩端螺旋体病感染病例数加到通过常规被动监测获得的数字中,那么2001年夏威夷的钩端螺旋体病年发病率将增加一倍多。这些发现表明,夏威夷许多钩端螺旋体感染病例未被诊断出来。在评估夏威夷居民和游客中出现急性发热疾病的患者时医生对钩端螺旋体病应保持高度怀疑。